BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35241665)

  • 41. Mast cells play a protumorigenic role in primary cutaneous lymphoma.
    Rabenhorst A; Schlaak M; Heukamp LC; Förster A; Theurich S; von Bergwelt-Baildon M; Büttner R; Kurschat P; Mauch C; Roers A; Hartmann K
    Blood; 2012 Sep; 120(10):2042-54. PubMed ID: 22837530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
    Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
    Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.
    Berger CL; Tigelaar R; Cohen J; Mariwalla K; Trinh J; Wang N; Edelson RL
    Blood; 2005 Feb; 105(4):1640-7. PubMed ID: 15514008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytogenetic findings in cell lines from cutaneous T-cell lymphoma.
    Kaltoft K; Hansen BH; Thestrup-Pedersen K
    Dermatol Clin; 1994 Apr; 12(2):295-304. PubMed ID: 8045039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients.
    de Masson A; Darbord D; Dobos G; Boisson M; Roelens M; Ram-Wolff C; Cassius C; Le Buanec H; de la Grange P; Jouenne F; Louveau B; Sadoux A; Bouaziz JD; Marie-Cardine A; Bagot M; Moins-Teisserenc H; Mourah S; Battistella M
    Blood; 2022 Mar; 139(12):1820-1832. PubMed ID: 34905599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update on Biology of Cutaneous T-Cell Lymphoma.
    Phyo ZH; Shanbhag S; Rozati S
    Front Oncol; 2020; 10():765. PubMed ID: 32477957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified.
    Peterson E; Weed J; Lo Sicco K; Latkowski JA
    Dermatol Clin; 2019 Oct; 37(4):455-469. PubMed ID: 31466586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis.
    Hu T; Krejsgaard T; Nastasi C; Buus TB; Nansen A; Hald A; Spee P; Nielsen PR; Blümel E; Gluud M; Willerslev-Olsen A; Woetmann A; Bzorek M; Eriksen JO; Ødum N; Rahbek Gjerdrum LM
    Dermatology; 2020; 236(2):123-132. PubMed ID: 31536992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation.
    Li G; Salhany KE; Rook AH; Lessin SR
    J Cutan Pathol; 1997 Aug; 24(7):403-8. PubMed ID: 9274957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
    Wood GS
    Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
    Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CCR10 is expressed in cutaneous T-cell lymphoma.
    Notohamiprodjo M; Segerer S; Huss R; Hildebrandt B; Soler D; Djafarzadeh R; Buck W; Nelson PJ; von Luettichau I
    Int J Cancer; 2005 Jul; 115(4):641-7. PubMed ID: 15700309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Invest Dermatol; 2012 Apr; 132(4):1280-9. PubMed ID: 22297640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
    Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
    Amber KT; Bloom R; Nouri K
    Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.
    Guenova E; Watanabe R; Teague JE; Desimone JA; Jiang Y; Dowlatshahi M; Schlapbach C; Schaekel K; Rook AH; Tawa M; Fisher DC; Kupper TS; Clark RA
    Clin Cancer Res; 2013 Jul; 19(14):3755-63. PubMed ID: 23785046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma.
    Stolearenco V; Levring TB; Nielsen HM; Lindahl L; Fredholm S; Kongsbak-Wismann M; Willerslev-Olsen A; Buus TB; Nastasi C; Hu T; Gluud M; Côme CRM; Krejsgaard T; Iversen L; Bonefeld CM; Grønbæk K; Met Ö; Woetmann A; Ødum N; Geisler C
    Dermatology; 2021; 237(2):283-290. PubMed ID: 32799209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
    Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
    J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.
    Krejsgaard T; Lindahl LM; Mongan NP; Wasik MA; Litvinov IV; Iversen L; Langhoff E; Woetmann A; Odum N
    Semin Immunopathol; 2017 Apr; 39(3):269-282. PubMed ID: 27717961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.